Chemistry Wealth Management’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ORCL
Chemistry Wealth Management's ORCL Position: Q3 2026 in Review
Chemistry Wealth Management reduced its Oracle (ORCL) stake by 4.1% in Q3 2026, selling an estimated $13.8K and leaving 2,283 shares worth $313K. The position accounts for 0.05% of the portfolio, ranked #169.
Chemistry Wealth Management first reported a position in ORCL in Q1 2022 and has held it in 19 quarters since. The position peaked at $9.43M in Q3 2025. 3,450 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.
- Chemistry Wealth Management held 2,283 shares of Oracle worth $313K as of Q3 2026.
- Chemistry Wealth Management sold 98 Oracle shares in Q3 2026, an estimated $13.8K.
- Oracle made up 0.05% of Chemistry Wealth Management's portfolio in Q3 2026, its #169 holding.
- Chemistry Wealth Management first reported a position in Oracle in Q1 2022 and has held it in 19 quarters since.
- Chemistry Wealth Management's Oracle position peaked at $9.43M in Q3 2025.
- 3,450 funds tracked by Wall St. Rank held Oracle as of Q3 2026.
Based on Chemistry Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.